Publications by authors named "Stephan Mathas"

Claim this Profile
R
Recombination junctions from antibody isotype switching classify immune and DNA repair dysfunction.
Clara Vázquez García, Benedikt Obermayer, Baerbel Keller, Mikhail Lebedin, Christoph Ratswohl, Stephan Mathas

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
At the crossroads of infection and malignancy: the challenge of tuberculosis in migrating populations - Case Report and Epidemiologic Analysis.
Hans-Jörg Epple, Teresa Domaszewska, Ann-Christin von Brünneck, Christian Furth, Steffen Dommerich, Stephan Mathas

BMC Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial.
Justin Ferdinandus, Gundolf Schneider, Alden Moccia, Richard Greil, Mark Hertzberg, Stephan Mathas

Lancet Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative DNA Methylation Profiling of Human and Murine ALK-Positive B-Cell Neoplasms.
Selina Glaser, Rabea Wagener, Shannon K Harkins, Claudia Voena, Susanne Bens, Stephan Mathas

Genes Chromosomes Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical in vitro and in vivo evidence for targeting CD74 as an effective treatment strategy for cutaneous T-cell lymphomas.
Mariantonia Costanza, Catello Giordano, Ann-Christin von Brünneck, Jing Zhao, Ahmad Makky, Stephan Mathas

Br J Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial.
Peter Borchmann, Justin Ferdinandus, Gundolf Schneider, Alden Moccia, Richard Greil, Stephan Mathas

Lancet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.
Torben Redmer, Martin Raigel, Christina Sternberg, Roman Ziegler, Clara Probst, Stephan Mathas

Mol Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial.
Elisabeth Schorb, Lisa Kristina Isbell, Andrea Kerkhoff, Stephan Mathas, Friederike Braulke

Lancet Haematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional reprogramming by mutated IRF4 in lymphoma.
Nikolai Schleussner, Pierre Cauchy, Vedran Franke, Maciej Giefing, Oriol Fornes, Stephan Mathas

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors.
Agnes Bonifacius, Britta Lamottke, Sabine Tischer-Zimmermann, Rebecca Schultze-Florey, Lilia Goudeva, Stephan Mathas

J Clin Invest· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DNA methylation status of the TERT promoter differs between subtypes of mature B-cell lymphomas.
Alexandra G Kouroukli, Anja Fischer, Helene Kretzmer, Emil Chteinberg, Nivethika Rajaram, Stephan Mathas

Blood Cancer J· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mouse models of human multiple myeloma subgroups.
Wiebke Winkler, Carlota Farré Díaz, Eric Blanc, Hanna Napieczynska, Patrick Langner, Stephan Mathas

Proc Natl Acad Sci U S A· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas.
Cristina Lopez, Nikolai Schleussner, Stephan H Bernhart, Kortine Kleinheinz, Stephanie Sungalee, Stephan Mathas

Haematologica· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.
Paul J Bröckelmann, Ina Bühnen, Julia Meissner, Karolin Trautmann-Grill, Peter Herhaus, Stephan Mathas

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency.

Sci Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma.
Anne Sophie Jacob, Helen Kaul, Michael Fuchs, Sarah Gillessen, Stefanie Kreissl, Stephan Mathas

Infection· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group.
Carla Damaschin, Helen Goergen, Stefanie Kreissl, Annette Plütschow, Frank Breywisch, Stephan Mathas

Leukemia· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals.
Sophy Denker, Aitomi Bittner, Mareike Frick, Julia Kase, Jörg Hoffmann, Stephan Mathas

Leuk Lymphoma· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL).
Kathrin D Wurster, Mariantonia Costanza, Stephan Kreher, Selina Glaser, Björn Lamprecht, Stephan Mathas

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma.
Huan-Chang Liang, Mariantonia Costanza, Nicole Prutsch, Mark W Zimmerman, Elisabeth Gurnhofer, Stephan Mathas

Nat Commun· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose glucocorticoid treatment of near-fatal bocavirus lung infection results in rapid recovery.
Matthias Obenaus, Oliver Schildgen, Dirk Schürmann, Ann-Christin von Brünneck, Martin Janz, Stephan Mathas

ERJ Open Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1.
Sarah Reinke, Paul J Bröckelmann, Ingram Iaccarino, Maria Garcia-Marquez, Sven Borchmann, Stephan Mathas

Blood· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.
Paul J Bröckelmann, Helen Goergen, Ulrich Keller, Julia Meissner, Rainer Ordemann, Stephan Mathas

JAMA Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global long terminal repeat activation participates in establishing the unique gene expression programme of classical Hodgkin lymphoma.
Benjamin Edginton-White, Pierre Cauchy, Salam A Assi, Sylvia Hartmann, Arthur G Riggs, Stephan Mathas

Leukemia· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma.
Linda von Hoff, Eva Kärgel, Vedran Franke, Erik McShane, Kathrin W Schulz-Beiss, Stephan Mathas

Blood· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis